UlrichSpecksMD
Pulmonology • Rochester, MNCritical Care Medicine, Interstitial Lung Diseases, Pleural Disease
Chair, Division of Pulmonary & Critical Care Medicine, Mayo Clinic Rochester
Dr. Specks is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st St Sw
Rochester, MN 55905Phone+1 507-284-2511
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Pulmonary Disease and Critical Care Medicine, 1987 - 1990- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1984 - 1986
University of Bonn Faculty of MedicineClass of 1981
Certifications & Licensure
MN State Medical License 1985 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Pulmonary Disease
Clinical Trials
- Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis Start of enrollment: 2005 Jan 01
- Longitudinal Study for Eosinophilic Granulomatosis With Polyangiitis Start of enrollment: 2006 Apr 01
- Longitudinal Protocol for Granulomatosis With Polyangiitis (Wegener's) and Microscopic Polyangiitis Start of enrollment: 2006 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 52 citationsDifferences between human proteinase 3 and neutrophil elastase and their murine homologues are relevant for murine model experiments.Olaf Wiesner, Robert D. Litwiller, Amber M. Hummel, Margaret A. Viss, Cari J. McDonald
FEBS Letters. 2005-10-10 - 276 citationsEosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management.Matthieu Groh, Christian Pagnoux, Chiara Baldini, Elisabeth H. Bel, Paolo Bottero
European Journal of Internal Medicine. 2015-09-01 - 510 citationsMepolizumab or Placebo for Eosinophilic Granulomatosis with PolyangiitisMichael E. Wechsler, Praveen Akuthota, David Jayne, Paneez Khoury, Amy D. Klion
The New England Journal of Medicine. 2017-05-17
Journal Articles
- Pulmonary Eosinophilic Granulomatosis with Polyangiitis Has IgG4 Plasma Cells and Immunoregulatory FeaturesZachary M Dong, Michael E Wechsler, Praveen Akuthota, Peter A Merkel, Ulrich Specks, Benjamin Raby, Frederic Clayton, The American Journal of Pathology
Other
- Cyclophosphamide pulmonary toxicitySpecks U
http://www.uptodate.com/contents/cyclophosphamide-pulmonary-toxicity
UpToDate, Wolters Kluwer Health - 2012-10-18
Press Mentions
Substudy of ADVOCATE Trial for ANCA-Associated Vasculitis Finds Avacopan Reduces Need for Glucocorticoids, Respiratory and ENT InvolvementMay 9th, 2022- Vasculitis Guidelines in Focus, Part 3: EGPASeptember 14th, 2021
Researchers Identify Possible New Treatment for Severe VasculitisJuly 14th, 2010
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
